Kevin Patrick Danahy, Chief Commercial Officer at PULSE BIOSCIENCES, INC. (PLSE), sold 40,400 shares at $18.49 ($747K) on 2025-09-18, disclosed to the SEC on 2025-09-22.
Scheduled sale ($747k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.49 | 20,000 | $370K | 49.5% |
| 2 | $18.49 | 20,000 | $370K | 49.5% |
| 3 | $18.48 | 400 | $7K | 1.0% |
| Total | $18.49 avg | 40,400 | $747K | 100% |
| Filing → |
| PLSE | SELL | 2026-02-11 | $1.4M | — | Filing → |
| PLSE | SELL | 2025-10-07 | $85K | — | Filing → |
| PLSE | BUY | 2023-11-17 | $35K | — | Filing → |